- Home
- XAIR vs BGLC Comparison
XAIR vs BGLC Comparison
Compare XAIR & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XAIR | BGLC |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 4.9M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XAIR | BGLC |
|---|---|---|
| Price | $0.38 | $2.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 228.3K | 10.3K |
| Earning Date | 06-16-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.09 | 45.78 |
| EPS | N/A | ★ N/A |
| Revenue | $3,705,000.00 | ★ $7,424,911.00 |
| Revenue This Year | $122.00 | N/A |
| Revenue Next Year | $58.15 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 219.67 | N/A |
| 52 Week Low | $0.15 | $1.92 |
| 52 Week High | $3.78 | $15.19 |
Technical Indicators
Market Signals| Indicator | XAIR | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 42.06 |
| Support Level | N/A | N/A |
| Resistance Level | $0.59 | $2.15 |
| Average True Range (ATR) | 0.05 | 0.22 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 3.71 | 72.96 |
Price Performance
Historical ComparisonAbout XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About BGLC BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.